Schedule 13D ownership disclosure
Iterum Therapeutics plc
Security class unavailable · CUSIP: 00BF3W0Q3
Event date: 2020-01-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,726,514
- Percent of class
- 11.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-006887
- Form type
- SC 13D
- Filer
- Iterum Therapeutics plc
- CIK
- CIK 1659323
- Filed
- Jan 27, 2020
- Reporting period
- Jan 16, 2020
- Description
- Schedule 13D beneficial ownership